Skip to main content
    V

    Voyager Therapeutics Inc (VYGR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.63
    -0.10 (-5.78%)

    Market Cap: $107.66M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Voyager Therapeutics Inc (VYGR) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Voyager Therapeutics are Minerva Neurosciences (NERV), Cassava Sciences (SAVA) and vTv Therapeutics (VTVT). By market cap, Voyager Therapeutics ranks 5th of the 13 companies on this page; Invivyd (IVVD) is the largest at $171.58M.

    Peer Comparison

    VYGR's revenue growth of -70.0% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Voyager Therapeutics (VYGR)$107.66MN/A4.0x0.0%N/A-70.0%0.00%
    Minerva Neurosciences Inc (NERV)$114.62MN/AN/A0.0%N/A0.0%0.00%
    Cassava Sciences Inc (SAVA)$114.97MN/AN/A0.0%N/A0.0%0.00%
    vTv Therapeutics Inc (VTVT)$78.99MN/AN/A-20.8%N/A0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Compass Therapeutics Inc. (CMPX)$139.35MN/AN/A0.0%N/A0.0%0.00%
    Tenaya Therapeutics Inc (TNYA)$79.59MN/AN/A0.0%N/A0.0%0.00%
    Vivani Medical Inc. (VANI)$91.11MN/AN/A0.0%N/A0.0%0.00%
    Pmv Pharmaceuticals Inc (PMVP)$95.93MN/AN/A0.0%N/A0.0%0.00%
    OUTLOOK THERAPEUTICS INC (OTLK)$100.54MN/AN/A0.0%-776.9%-99.4%0.00%
    Genelux Corporation Common Stock (GNLX)$84.38MN/AN/A0.0%N/A-95.3%0.00%
    Cognition Therapeutics Inc (CGTX)$64.65MN/AN/A0.0%N/A0.0%0.00%
    Invivyd Inc. (IVVD)$171.58MN/A2.9x-183.9%N/A21.2%0.00%
    Peer median$93.52MN/A2.9x0.0%-518.7%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Voyager Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Minerva Neurosciences Inc (NERV)
    Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products...
    NERV competitors
    Cassava Sciences Inc (SAVA)
    Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
    vTv Therapeutics Inc (VTVT)
    vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet...
    VTVT competitors
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Compass Therapeutics Inc. (CMPX)
    Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing proprietary antibody-based therapies to treat multiple...
    CMPX competitors
    Tenaya Therapeutics Inc (TNYA)
    Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary...
    TNYA competitors
    Vivani Medical Inc. (VANI)
    Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery...
    VANI competitors
    Pmv Pharmaceuticals Inc (PMVP)
    PMV Pharmaceuticals, Inc., a precision oncology company, is dedicated to the discovery and development of small molecule tumor agnostic therapies for p53...
    PMVP competitors
    OUTLOOK THERAPEUTICS INC (OTLK)
    Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic...
    OTLK competitors
    Genelux Corporation Common Stock (GNLX)
    Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering...
    GNLX competitors
    Cognition Therapeutics Inc (CGTX)
    Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting...
    CGTX competitors
    Invivyd Inc. (IVVD)
    Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery...
    IVVD competitors

    Frequently Asked Questions About VYGR

    Who are Voyager Therapeutics' main competitors?

    The companies most similar to Voyager Therapeutics include Minerva Neurosciences (NERV), Cassava Sciences (SAVA), vTv Therapeutics (VTVT), Neumora Therapeutics (NMRA) and Compass Therapeutics (CMPX), listed from the closest match.

    Who is Voyager Therapeutics' biggest competitor?

    Invivyd (IVVD) is the largest of the similar companies at $171.58M; Minerva Neurosciences (NERV) is the closest match by business profile, size, sector and industry.

    How does VYGR stock compare with its competitors?

    VYGR's P/S is 4.0x against a peer median of 2.9x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Voyager Therapeutics' competitors pays a higher dividend?

    Voyager Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Voyager Therapeutics bigger than its competitors?

    No. Voyager Therapeutics is 5th by market cap among the 13 companies on this page; the largest is Invivyd (IVVD) at $171.58M.